Leveraging new and innovative technologies can provide efficiencies and make it easier for pharmacovigilance teams to perform advanced tasks. Many companies are adopting modern applications or upgrading internal systems to reduce overhead and get more from their investments.
Read this white paper to learn about 9 key considerations pharmacovigilance teams examine when evaluating new safety solutions.
Who Will Benefit
• Biosafety professional
• Safety manager
• Risk manager
• Regulatory specialist
• Head of PV
• Head of PV IT
• Head of Safety Operations
• Safety Specialists
• EU QPPV
• Safety Scientist
• Aggregate Report Specialist
• PV Agreements Specialist
• PSMF Coordinator
• Medical Reviewers